Elastic N.V. - ESTC

ESTC Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ESTC	0.4	4.0	-6.4	22.0	-13.1	-13.6	11.4	42.5	43.4	43.4
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare ESTC with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ESTC
name	Elastic N.V.
price	100.39
changes percentage	0.4201
change	0.42
day low	100
day high	101.59
year high	136.06
year low	69
market cap	10403616480
price avg 50	99.8322
price avg 200	98.6672
exchange	NYSE
volume	987037
avg volume	1396483
open	100.98
previous close	99.97
eps	0.6
pe	167.32
earnings announcement	2025-02-27T12:00:00.000+0000
shares outstanding	103632000
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 76.3%

Overall Quarterly Financial Health: 57.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001707753
revenue	1267321000	1068989000	18.55
gross profit	937242000	772363000	21.35
gross profit ratio	0.74	0.72	2.36
research and development expenses	341951000	313454000	9.09
operating expenses	1068573999	960238000	11.28
interest income	0	7459000	-100.00
interest expense	26132000	25159000	3.87
ebitda	-78625000	-171485000	54.15
ebitdaratio	-0.06	-0.13	52.69
operating income	-129902000	-187875000	30.86
operating income ratio	-0.1	-0.18	41.68
net income	61720000	-236161000	126.13
net income ratio	0.05	-0.22	122.04
eps	0.62	-2.47	125.10

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,267 million in 2024 from 1,069 million in 2023 representing a change of 18.55%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 937 million in 2024 from 772 million in 2023 representing a change of 21.35%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 342 million in 2024 from 313 million in 2023 representing a change of 9.09%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 1,069 million in 2024 from 960 million in 2023 representing a change of 11.28%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -79 million in 2024 from -171 million in 2023 representing a change of 54.15%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 62 million in 2024 from -236 million in 2023 representing a change of 126.13%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.62 in 2024 from 0.62 in 2023 representing a change of 125.1%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Income: Operating income decreased to -130 million in 2024 from -188 million in 2023 representing a change of 30.86%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001707753
revenue	365361000	347420000	5.16
gross profit	272182000	255663000	6.46
gross profit ratio	0.74	0.74	1.23
research and development expenses	88163000	89332000	-1.31
operating expenses	276608000	289362000	-4.41
interest income	0	0	NaN
interest expense	6462000	6526000	-0.98
ebitda	8245000	-18457000	144.67
ebitdaratio	0.02	-0.05	142.48
operating income	-4426000	-33651000	86.85
operating income ratio	-0.01	-0.1	87.49
net income	-25450000	-49227000	48.30
net income ratio	-0.07	-0.14	50.84
eps	0.48	-0.48	200.00

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 365 million in 2025Q2 from 347 million in 2025Q1 representing a change of 5.16%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 272 million in 2025Q2 from 256 million in 2025Q1 representing a change of 6.46%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 277 million in 2025Q2 from 289 million in 2025Q1 representing a change of -4.41%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 8 million in 2025Q2 from -18 million in 2025Q1 representing a change of 144.67%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to -4 million in 2025Q2 from -34 million in 2025Q1 representing a change of 86.85%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 0.48 in 2025Q2 from 0.48 in 2025Q1 representing a change of 200.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 88 million in 2025Q2 from 89 million in 2025Q1 representing a change of -1.31%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Net Income: Net income decreased to -25 million in 2025Q2 from -49 million in 2025Q1 representing a change of 48.3%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001707753
total assets	2242566000	1743482000	28.63
total liabilities	1504381000	1344585000	11.88
total equity	738185000	398897000	85.06
cash and cash equivalents	540397000	644167000	-16.11
short term investments	544002000	271041000	100.71
long term investments	461000	0	NaN
total current assets	1530897000	1274280000	20.14
total non current assets	711669000	469202000	51.68
total current liabilities	871091000	716619000	21.56
total non current liabilities	633290000	627966000	0.85
common stock	1070000	1024000	4.49
retained earnings	-991607000	-1053327000	5.86
total debt	593697000	594234000	-0.09

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,243 million in 2024 from 1,743 million in 2023 representing a change of 28.63%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 738 million in 2024 from 399 million in 2023 representing a change of 85.06%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 544 million in 2024 from 271 million in 2023 representing a change of 100.71%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,531 million in 2024 from 1,274 million in 2023 representing a change of 20.14%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2024 from 1 in 2023 representing a change of 4.49%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -992 million in 2024 from -1,053 million in 2023 representing a change of 5.86%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 594 million in 2024 from 594 million in 2023 representing a change of -0.09%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,504 million in 2024 from 1,345 million in 2023 representing a change of 11.88%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 540 million in 2024 from 644 million in 2023 representing a change of -16.11%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 871 million in 2024 from 717 million in 2023 representing a change of 21.56%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001707753
total assets	2231500000	2150473000	3.77
total liabilities	1419982000	1391055000	2.08
total equity	811518000	759418000	6.86
cash and cash equivalents	658508000	594871000	10.70
short term investments	539062000	552459000	-2.42
long term investments	0	0	NaN
total current assets	1575754000	1466148000	7.48
total non current assets	655746000	684325000	-4.18
total current liabilities	790729000	768219000	2.93
total non current liabilities	629253000	622836000	1.03
common stock	1091000	1081000	0.93
retained earnings	-1066284000	-1040834000	-2.45
total debt	20146000	590744000	-96.59

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,232 million in 2025Q2 from 2,150 million in 2025Q1 representing a change of 3.77%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 812 million in 2025Q2 from 759 million in 2025Q1 representing a change of 6.86%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 659 million in 2025Q2 from 595 million in 2025Q1 representing a change of 10.7%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,576 million in 2025Q2 from 1,466 million in 2025Q1 representing a change of 7.48%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2025Q2 from 1 in 2025Q1 representing a change of 0.93%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 20 million in 2025Q2 from 591 million in 2025Q1 representing a change of -96.59%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,420 million in 2025Q2 from 1,391 million in 2025Q1 representing a change of 2.08%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 539 million in 2025Q2 from 552 million in 2025Q1 representing a change of -2.42%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 791 million in 2025Q2 from 768 million in 2025Q1 representing a change of 2.93%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -1,066 million in 2025Q2 from -1,041 million in 2025Q1 representing a change of -2.45%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0001707753
net change in cash	-103551000	-216997000	52.28
operating cash flow	148762000	35662000	317.14
free cash flow	145312000	32978000	340.63
capital expenditure	-3450000	-2684000	-28.54
depreciation and amortization	17999000	20233000	-11.04
deferred income tax	-217195000	-2007000	-10721.87
stock based compensation	239137000	204039000	17.20
accounts payables	-9998000	6304000	-258.60
inventory	0	0	NaN
acquisitions net	-19100000	0	NaN
investments in property plant and equipment	-3450000	-2684000	-28.54
net cash used for investing activites	-287960000	-272952000	-5.50
debt repayment	0	0	NaN
common stock issued	40054000	17471000	129.26
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	40054000	17471000	129.26
cash at end of period	543089000	646640000	-16.01
accounts receivables	-63519000	-46353000	-37.03
cash at beginning of period	646640000	863637000	-25.13

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -104 million in 2024 from -217 million in 2023 representing a change of 52.28%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 149 million in 2024 from 36 million in 2023 representing a change of 317.14%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 145 million in 2024 from 33 million in 2023 representing a change of 340.63%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -3 million in 2024 from -3 million in 2023 representing a change of -28.54%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -64 million in 2024 from -46 million in 2023 representing a change of -37.03%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 239 million in 2024 from 204 million in 2023 representing a change of 17.2%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 10 million in 2024 from 6 million in 2023 representing a change of -258.6%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q2	2025Q1	Q/Q change %
0001707753
operating cash flow	38377000	52754000	-27.25
free cash flow	37662000	52007000	-27.58
capital expenditure	-715000	-747000	4.28
depreciation and amortization	-561000	4173000	-113.44
deferred income tax	23653000	14723000	60.65
stock based compensation	64065000	63543000	0.82
accounts receivables	-59122000	127203000	-146.48
accounts payables	14065000	-16400000	185.76
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-715000	-747000	4.28
net cash used for investing activites	14287000	-3520000	505.88
debt repayment	0	0	NaN
common stock issued	5719000	4745000	20.53
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	12246000	4745000	158.08
net change in cash	63521000	55218000	15.04
cash at end of period	661828000	598307000	10.62
cash at beginning of period	598307000	543089000	10.17

Overall Score of Quarterly Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 64 million in 2025Q2 from 55 million in 2025Q1 representing a change of 15.04%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 14 million in 2025Q2 from 16 million in 2025Q1 representing a change of 185.76%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -59 million in 2025Q2 from 127 million in 2025Q1 representing a change of -146.48%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 38 million in 2025Q2 from 53 million in 2025Q1 representing a change of -27.25%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 38 million in 2025Q2 from 52 million in 2025Q1 representing a change of -27.58%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -1 million in 2025Q2 from -1 million in 2025Q1 representing a change of 4.28%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 24 million in 2025Q2 from 15 million in 2025Q1 representing a change of 60.65%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 64 million in 2025Q2 from 64 million in 2025Q1 representing a change of 0.82%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2025 Earnings call transcript
Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-04-30	2023-04-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	12.72	11.17	13.89
net income per share	0.62	-2.47	125.11
operating cash flow per share	1.49	0.37	300.75
free cash flow per share	1.46	0.34	323.31
cash per share	10.88	9.56	13.83
book value per share	7.41	4.17	77.78
tangible book value per share	4.0	0.69	478.28
shareholders equity per share	7.41	4.17	77.78
interest debt per share	6.22	6.47	-3.86
market cap	10185837732.82	5404906992.24	88.46
enterprise value	10239137732.82	5354973992.24	91.21
pe ratio	165.03	-22.89	821.09
price to sales ratio	8.04	5.06	58.96
pocfratio	68.47	151.56	-54.82
pfcf ratio	70.1	163.89	-57.23
pb ratio	13.8	13.55	1.84
ptb ratio	13.8	13.55	1.84
ev to sales	8.08	5.01	61.28
enterprise value over ebitda	-130.23	-31.23	-317.03
ev to operating cash flow	68.83	150.16	-54.16
ev to free cash flow	70.46	162.38	-56.61
earnings yield	0.01	-0.04	113.87
free cash flow yield	0.01	0.01	133.81
debt to equity	0.8	1.49	-46.01
debt to assets	0.26	0.34	-22.33
net debt to ebitda	-0.68	0.29	-332.81
current ratio	1.76	1.78	-1.17
interest coverage	-4.97	-7.47	33.43
income quality	2.41	-0.15	1696.13
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.13	0.13	-5.41
research and ddevelopement to revenue	0.27	0.29	-7.98
intangibles to total assets	0.15	0.19	-20.56
capex to operating cash flow	0.02	0.08	-69.19
capex to revenue	0.0	0.0	8.42
capex to depreciation	0.19	0.13	44.49
stock based compensation to revenue	0.19	0.19	-1.14
graham number	10.16	15.21	-33.19
roic	0.05	-0.19	124.07
return on tangible assets	0.03	-0.17	119.38
graham net net	-1.78	-2.14	16.53
working capital	659806000	557661000	18.32
tangible asset value	398185000	66151000	501.93
net current asset value	26516000	-70305000	137.72
invested capital	1025765000	915496000	12.04
average receivables	291965000	238073500	22.64
average payables	30613000	31777000	-3.66
average inventory	29143000	52301000	-44.28
days sales outstanding	93.03	89.09	4.42
days payables outstanding	28.83	43.25	-33.34
days of inventory on hand	0	71.72	-100.00
receivables turnover	3.92	4.1	-4.24
payables turnover	12.66	8.44	50.01
inventory turnover	0	5.09	-100.00
roe	0.08	-0.59	114.12
capex per share	0.03	0.03	23.49

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 165.03 on 2024-04-30 from -22.89 on 2023-04-30, representing a change of 821.09%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.80 on 2024-04-30 from 1.49 on 2023-04-30, representing a change of -46.01%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.76 on 2024-04-30 from 1.78 on 2023-04-30, representing a change of -1.17%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-10-31 Q2	2024-07-31 Q1	Q/Q change %
ESTC
calendar year	2025	2025	NaN
revenue per share	3.54	3.4	4.19
net income per share	-0.25	-0.48	48.78
operating cash flow per share	0.37	0.52	-27.93
free cash flow per share	0.36	0.51	-28.25
cash per share	11.6	11.22	3.41
book value per share	7.86	7.42	5.87
tangible book value per share	4.63	4.13	11.95
shareholders equity per share	7.86	7.42	5.87
interest debt per share	0.26	5.84	-95.59
market cap	8282844110.2	11217533986.45	-26.16
enterprise value	7644482110.2	11213406986.45	-31.83
pe ratio	-81.36	-56.97	-42.82
price to sales ratio	22.67	32.29	-29.79
pocfratio	215.83	212.64	1.50
pfcf ratio	219.93	215.69	1.96
pb ratio	10.21	14.77	-30.90
ptb ratio	10.21	14.77	-30.90
ev to sales	20.92	32.28	-35.17
enterprise value over ebitda	927.17	-607.54	252.61
ev to operating cash flow	199.19	212.56	-6.29
ev to free cash flow	202.98	215.61	-5.86
earnings yield	-0.0	-0.0	29.98
free cash flow yield	0.0	0.0	-1.92
debt to equity	0.02	0.78	-96.81
debt to assets	0.01	0.27	-96.71
net debt to ebitda	-77.42	0.22	-34726.05
current ratio	1.99	1.91	4.42
interest coverage	-0.68	-5.16	86.72
income quality	-1.51	-1.07	-40.71
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.12	0.12	-1.76
research and ddevelopement to revenue	0.24	0.26	-6.15
intangibles to total assets	0.15	0.16	-4.44
capex to operating cash flow	0.02	0.01	31.57
capex to revenue	0.0	0.0	-8.98
capex to depreciation	-1.27	0.18	-811.99
stock based compensation to revenue	0.18	0.18	-4.13
graham number	6.6	8.97	-26.36
roic	-0.04	-0.04	-7.67
return on tangible assets	-0.01	-0.03	50.59
graham net net	-0.29	-0.94	68.79
working capital	785025000	697929000	12.48
tangible asset value	477595000	422660000	13.00
net current asset value	155772000	75093000	107.44
invested capital	1140386000	1057398000	7.85
average receivables	226271000	259742500	-12.89
average payables	16447000	17706000	-7.11
average inventory	0	0.5	-100.00
days sales outstanding	63.08	50.9	23.93
days payables outstanding	22.75	9.16	148.45
days of inventory on hand	0	0	NaN
receivables turnover	1.43	1.77	-19.31
payables turnover	3.96	9.83	-59.75
inventory turnover	0	0	NaN
roe	-0.03	-0.06	51.62
capex per share	0.01	0.01	-5.17

• Negative

  ROE: Return on Equity (ROE) increased to -0.03 on 2024-10-31 Q2 from -0.06 on 2024-07-31 Q1, representing a change of 51.62%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -81.36 on 2024-10-31 Q2 from -56.97 on 2024-07-31 Q1, representing a change of -42.82%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.99 on 2024-10-31 Q2 from 1.91 on 2024-07-31 Q1, representing a change of 4.42%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.02 on 2024-10-31 Q2 from 0.78 on 2024-07-31 Q1, representing a change of -96.81%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 10.5 which is lower than current price 100.39, indicates the company may be overvalued.